The Promise of Partial Cellular Reprogramming For twenty years, researchers have known how to reset a cell’s internal clock ...
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Life Biosciences ("Life Bio"), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today ...
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy designed to reverse cellular aging in the human eye. The trial, registered as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results